Gulf International Bank (Uk) LTD Horizon Therapeutics Public LTD CO Transaction History

Gulf International Bank (Uk) LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$98.98 - $115.74 $168,167 - $196,642	-1,699 Reduced 7.82%	20,020 $2.32 Million
Q2 2023 Aug 02, 2023	SELL	$96.34 - $112.38 $620,718 - $724,064	-6,443 Reduced 22.88%	21,719 $2.23 Million
Q1 2023 Apr 12, 2023	SELL	$107.32 - $113.5 $1.25 Million - $1.32 Million	-11,620 Reduced 29.21%	28,162 $3.07 Million
Q4 2021 Jan 24, 2022	SELL	$98.56 - $119.91 $818,048 - $995,253	-8,300 Reduced 17.26%	39,782 $4.29 Million
Q3 2021 Nov 10, 2021	SELL	$91.91 - $110.37 $49,631 - $59,599	-540 Reduced 1.11%	48,082 $5.27 Million
Q2 2021 Aug 10, 2021	BUY	$86.24 - $95.92 $181,104 - $201,432	2,100 Added 4.51%	48,622 $4.55 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $402,248 - $534,688	-5,600 Reduced 10.74%	46,522 $4.28 Million
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $3.49 Million - $4.4 Million	52,122 New	52,122 $3.81 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.